PT-141 (Bremelanotide) · Research brief

PT-141 IU per Tick Insulin Syringe — Dosing Precision Guide

Q: How many IU per tick on a standard insulin syringe for PT-141?

A U-100 insulin syringe has 100 tick marks representing 100 IU total, with each tick equal to 1 IU or 0.01ml. For PT-141 dosing, ignore the IU scale entirely — you’re measuring volume (ml), not insulin units. Each tick represents 0.01ml, and the actual peptide dose per tick depends on your reconstitution concentration. For example, 10mg PT-141 in 2ml water yields 50mcg per 0.01ml tick.

Q: What happens if I use the IU markings instead of ml for PT-141 dosing?

Using IU markings without converting to milliliters creates dosing errors because PT-141 is measured in milligrams of compound mass, not insulin-specific biological units. The IU scale assumes a fixed insulin concentration of 100 units per ml — PT-141 concentration varies based on how much diluent you added during reconstitution. Always use the ml scale (or convert IU to ml by dividing by 100) and calculate dose based on your peptide concentration.

Q: Can I use a tuberculin syringe instead of an insulin syringe for PT-141?

Yes — tuberculin syringes offer identical 0.01ml precision without IU labeling, which eliminates conversion confusion entirely. They’re preferred in laboratory settings for peptide administration because the ml-only scale matches how peptides are dosed (by mass and volume, not biological units). The drawback is cost: tuberculin syringes typically cost 2–3× more than standard U-100 insulin syringes and may be harder to source outside medical supply distributors.

Q: What is the safest reconstitution ratio for PT-141 to minimize dosing errors?

A 2ml reconstitution (10mg peptide in 2ml bacteriostatic water) balances precision and practicality — it yields 50mcg per tick, meaning common doses like 1mg (20 ticks) and 1.5mg (30 ticks) land on easy-to-read syringe marks. Ratios below 2ml increase concentration but reduce shelf life and make tick counting less forgiving; ratios above 3ml require larger injection volumes and push doses beyond 40–50 ticks, increasing meniscus reading error.

Q: How do I verify my syringe is measuring accurately before first use?

After reconstitution, draw exactly 0.1ml (10 ticks on a U-100 syringe) of the peptide solution and verify the liquid level aligns precisely with the 10-tick mark under direct lighting. If the meniscus sits above or below the mark, your syringe may be defective or you’ve misread the scale. Repeat with a second syringe from the same batch — consistent misalignment indicates a manufacturing defect; inconsistent readings suggest user error in meniscus interpretation.

Q: What should I do if I lose track of my reconstitution ratio mid-protocol?

Measure the remaining liquid volume in the vial using a fresh syringe — draw the solution to the 1ml mark and note the actual volume. Subtract any doses already administered (if documented) from the original total to estimate the starting concentration. If you cannot reconstruct the ratio with confidence, discard the vial and reconstitute fresh peptide with documented measurements. Guessing the concentration mid-study creates compounding dosing errors that invalidate the entire dataset.

Q: Does PT-141 dose per tick change if I store the reconstituted vial for multiple weeks?

The concentration (and therefore dose per tick) remains constant as long as the peptide stays dissolved and refrigerated at 2–8°C. What changes is peptide degradation over time — bacteriostatic water extends stability to 28 days, but potency declines gradually after that. The tick calculation stays mathematically correct, but the pharmacological dose decreases as the peptide degrades. For studies requiring stable dosing across 4+ weeks, prepare smaller-volume reconstitutions (e.g., 5mg in 1ml) and replace the vial every 21 days.

Q: Can I use a U-40 insulin syringe for PT-141 if U-100 syringes are unavailable?

Avoid U-40 syringes — each tick represents 0.025ml instead of 0.01ml, creating 2.5× less precision than U-100 syringes. This margin of error compounds across multiple doses and makes sub-milligram dosing unreliable. U-40 syringes are designed for veterinary insulin use and are incompatible with human peptide research protocols requiring hundredth-of-a-milliliter accuracy. Source U-100 syringes or tuberculin syringes instead.

Q: Why do some reconstitution protocols recommend 1ml while others recommend 3ml for the same peptide?

Lower diluent volumes (1ml) create higher concentrations, reducing injection volume but shortening refrigerated shelf life to 14–21 days due to increased peptide density and proximity of molecules in solution. Higher volumes (3ml) extend stability to 28–30 days by reducing concentration and molecular interaction but require larger injection volumes. Choose based on study duration: rapid-use protocols favor 1ml; extended multi-week studies favor 2–3ml.

Q: What is the most common PT-141 dosing mistake researchers make with insulin syringes?

Forgetting or misremembering the reconstitution ratio after the first dose — leading to either 50% underdosing (thinking 1ml when you used 2ml) or 100% overdosing (thinking 2ml when you used 1ml). The solution: immediately label the vial with concentration (mg/ml) and calculated dose per tick (mcg). Memory-based dosing is the leading cause of protocol failures in peptide research — documentation prevents this entirely.

Real Peptides Research TeamEditorial

Updated April 23, 202610 min read

57 WORDS

Short answer

Those tiny tick marks on your insulin syringe aren't just reference lines. They're the difference between a therapeutic dose and a wasted injection. Miss the IU-to-tick conversion and you've either underdosed by half or doubled your intended amount without realizing it. PT-141 (bremelanotide) dosing in research settings demands precision at the hundredth-of-a-milliliter level, and standard insulin syringes.

Key takeaways

A standard U-100 insulin syringe contains 100 tick marks, with each tick representing 0.01ml. The IU label is irrelevant for peptide dosing and refers only to insulin-specific calibration.
PT-141 dose per tick is determined by reconstitution concentration: 10mg in 2ml yields 50mcg per tick, meaning a 1mg dose requires exactly 20 ticks on the syringe barrel.
Tuberculin syringes eliminate IU confusion entirely by marking only milliliters, but U-100 insulin syringes remain the research standard due to cost and availability.
Write the calculated mcg-per-tick value directly on the vial label immediately after reconstitution. Memory-based dosing is the leading cause of protocol errors across multi-session studies.
Reconstitution ratio affects both dose accuracy and peptide stability: 1ml ratios maximize concentration but reduce refrigerated shelf life to 14–21 days, while 3ml ratios extend stability to 30 days at the cost of larger injection volumes.

Our team has worked with researchers reconstituting peptides across hundreds of protocols. The single most common error isn't contamination or oxidation. It's miscalculating the dose-per-tick relationship based on reconstitution ratio. Get the math wrong once and every subsequent injection perpetuates the same error.

How many IU per tick on an insulin syringe for PT-141 dosing?

A standard 1ml insulin syringe (U-100) contains 100 tick marks, with each tick representing 0.01ml or 10 IU. For PT-141 reconstituted at typical research ratios (e.g., 10mg peptide in 2ml bacteriostatic water), each 0.01ml tick delivers a specific microgram dose determined by your reconstitution concentration. Not a fixed IU amount, because PT-141 is measured in milligrams, not insulin units.

The confusion starts with terminology. Insulin syringes are calibrated in IU (International Units) because insulin is dosed in units of biological activity. PT-141 is dosed in milligrams or micrograms of actual compound mass. The syringe doesn't know what's inside it. You're converting volume (ml) to mass (mg) based on the concentration you created during reconstitution. That's the calculation most first-time users miss.

This guide covers the exact IU-to-tick math for standard syringe types, how reconstitution ratio changes dose-per-tick, the three syringe errors that waste peptide or create overdose risk, and the measurement verification protocol Real Peptides uses internally before any research administration.

Understanding Insulin Syringe Calibration for Peptide Use

Insulin syringes measure volume in two overlapping scales: milliliters (ml) and International Units (IU). A U-100 syringe. The standard type used globally for insulin administration. Is calibrated so that 1ml equals 100 IU. Each small tick mark on the barrel represents 1 IU, which equals 0.01ml. A half-unit syringe (0.5ml total capacity) contains 50 ticks; a full 1ml syringe contains 100 ticks.

Here's what matters for PT-141: the IU measurement is irrelevant to peptide dosing. You're using the syringe purely as a volume measurement tool. When a protocol calls for 1mg (1000mcg) of PT-141, you need to know how many milliliters that represents based on your reconstitution concentration. Then convert that milliliter volume into tick marks on the syringe barrel.

Example: You reconstitute 10mg of lyophilized PT-141 in 2ml of bacteriostatic water. Your concentration is 10mg/2ml = 5mg/ml, or 5000mcg/ml. To dose 1mg (1000mcg), you need 1000mcg ÷ 5000mcg/ml = 0.2ml. On a U-100 insulin syringe, 0.2ml equals 20 ticks (because each tick is 0.01ml). The syringe label might say '20 IU' at that mark. Ignore it. You're measuring 0.2ml of a 5mg/ml solution.

Researchers working with Dihexa or other precision-dosed peptides face the same conversion requirement. The syringe type doesn't change, but the reconstitution math does.

Calculating PT-141 Dose Per Tick Based on Reconstitution Ratio

The dose delivered per tick depends entirely on how you reconstituted the peptide. Standard reconstitution ratios for 10mg PT-141 vials include 1ml, 2ml, or 3ml of bacteriostatic water. Each creates a different concentration, which changes the microgram-per-tick value.

10mg PT-141 in 1ml bacteriostatic water: Concentration = 10mg/ml = 10,000mcg/ml. Each 0.01ml tick = 100mcg.

10mg PT-141 in 2ml bacteriostatic water: Concentration = 5mg/ml = 5,000mcg/ml. Each 0.01ml tick = 50mcg.

10mg PT-141 in 3ml bacteriostatic water: Concentration = 3.33mg/ml = 3,330mcg/ml. Each 0.01ml tick = 33.3mcg.

Most research protocols target doses between 500mcg and 2mg (2000mcg). Using the 2ml reconstitution example (50mcg per tick): a 1mg dose requires 20 ticks (1.0mg ÷ 50mcg = 20). A 1.5mg dose requires 30 ticks. A 2mg dose requires 40 ticks.

Write this calculation on the vial label immediately after reconstitution. Don't rely on memory. We've reviewed protocols where researchers used the same vial across multiple sessions and forgot whether they'd reconstituted at 1ml or 2ml. Resulting in 2× dosing errors across an entire study cohort.

Peptides like Cerebrolysin follow identical reconstitution math. The compound changes, the volumetric principle doesn't.

Syringe Type Comparison: U-100 vs U-50 vs Tuberculin

Syringe Type	Total Capacity	Tick Increment	Best Use Case	PT-141 Suitability	Measurement Precision
U-100 Insulin (1ml)	1ml / 100 IU	0.01ml per tick	Standard peptide dosing 0.1–1ml	Excellent for doses 500mcg–2mg	±0.01ml (10mcg at 1mg/ml concentration)
U-50 Insulin (0.5ml)	0.5ml / 50 IU	0.01ml per tick	Low-volume precision dosing <0.5ml	Ideal for microdosing protocols <1mg	±0.01ml (same precision, half the capacity)
Tuberculin (1ml)	1ml	0.01ml per tick (no IU markings)	Laboratory-grade volume measurement	Excellent. Avoids IU confusion entirely	±0.01ml (clearest ml-only scale)
U-40 Insulin (1ml)	1ml / 40 IU	0.025ml per tick	Veterinary insulin (non-standard for human peptides)	Poor. Tick increments too coarse for PT-141	±0.025ml (2.5× less precise than U-100)

The U-100 insulin syringe is the standard for subcutaneous peptide research because it balances precision (0.01ml ticks) with sufficient volume capacity (up to 1ml total). Tuberculin syringes offer identical precision without IU labeling, which eliminates the mental conversion step entirely. But they're less widely available and cost 2–3× more per unit.

Avoid U-40 syringes (common in veterinary settings). Their 0.025ml tick increments create a 2.5× margin of error compared to U-100 syringes, which compounds across titration protocols.

PT-141 IU per Tick Insulin Syringe: Standard Protocols Comparison

Reconstitution Ratio	Concentration (mg/ml)	Dose per Tick (mcg)	1mg Dose (ticks)	1.5mg Dose (ticks)	2mg Dose (ticks)	Professional Assessment
10mg in 1ml	10mg/ml	100mcg	10 ticks	15 ticks	20 ticks	Highest concentration. Smallest injection volume but shortest shelf stability (14–21 days refrigerated). Best for single-researcher protocols with rapid use cycles.
10mg in 2ml	5mg/ml	50mcg	20 ticks	30 ticks	40 ticks	Balanced ratio. Extends shelf life to 28 days while keeping injection volume manageable. Industry standard for multi-week research protocols.
10mg in 3ml	3.33mg/ml	33.3mcg	30 ticks	45 ticks	60 ticks	Lowest concentration. Maximizes shelf stability (up to 30 days) but requires larger injection volumes. Optimal for microdosing studies or extended-duration protocols.

What If: PT-141 Dosing Scenarios

What If I Used the Wrong Reconstitution Volume and Already Dosed Once?

Stop immediately and recalculate before the next administration. Measure the remaining liquid volume in the vial using a fresh syringe. Draw to the 1ml mark and note the actual tick count. If you reconstituted with 2ml but thought you used 1ml, your first dose was 50% of intended (e.g., 500mcg instead of 1mg). Document the error, recalculate the correct tick count for your actual concentration, and resume at the proper dose. One missed dose creates a data gap but doesn't compromise safety. Doubling up to 'catch up' does.

What If the Syringe Has Both IU and ml Markings — Which Do I Follow?

Ignore the IU scale entirely. Use only the ml markings on the opposite side of the barrel. The IU scale assumes you're measuring insulin at U-100 concentration (100 units per ml). PT-141 isn't measured in units. It's measured in milligrams of peptide mass. Following the IU scale creates a conceptual error that leads to dosing mistakes. If your syringe only shows IU marks, convert manually: divide the IU number by 100 to get milliliters (e.g., 20 IU = 0.2ml).

What If I Need to Dose Below 10 Ticks (0.1ml) on a U-100 Syringe?

Switch to a U-50 (0.5ml) insulin syringe or a tuberculin syringe. Both provide the same 0.01ml tick precision but with a smaller total barrel, making sub-0.1ml doses easier to measure accurately. A U-100 syringe can technically measure down to 1 tick (0.01ml), but at volumes that low, the meniscus error margin (the curved liquid surface) becomes significant relative to total dose. For doses requiring fewer than 10 ticks, reconstitute at a lower concentration (e.g., 10mg in 3ml instead of 1ml) so the target dose spans more ticks on the barrel.

What If the Peptide Looks Cloudy After Reconstitution — Does That Affect Tick Calculation?

Cloudiness indicates incomplete dissolution or protein aggregation. This is a quality failure, not a measurement issue. The tick calculation remains mathematically correct, but the peptide may be degraded and no longer pharmacologically active. Do not inject cloudy solutions. PT-141 reconstituted properly in bacteriostatic water should be completely clear with no visible particulates. Cloudiness suggests temperature excursion during shipping, contaminated diluent, or expired peptide. Discard the vial and start with a fresh reconstitution using a new peptide aliquot and verified sterile bacteriostatic water.

The Unforgiving Truth About PT-141 Dosing Errors

Here's the honest answer: most PT-141 dosing mistakes aren't caused by contamination, oxidation, or expired peptide. They're caused by researchers who assume the IU markings on an insulin syringe apply to peptide dosing. They don't. Not even close. The IU scale measures insulin-specific biological activity at a fixed concentration. PT-141 is dosed in milligrams of chemical mass, which changes based on how much diluent you added during reconstitution. Using the IU number without converting to milliliters first means you're measuring the wrong thing entirely.

The second most common error: forgetting which reconstitution ratio you used. We've reviewed protocols where a 2ml reconstitution was mistaken for 1ml three doses into a study. Every prior administration was half the intended dose, invalidating the entire dataset. Write the concentration on the vial. Write the mcg-per-tick value. Don't rely on memory, labels from prior batches, or assumptions about 'standard' reconstitution. There is no standard until you create one and document it.

The margin for error at research-grade peptide dosing is zero. A 10% variance in dose might be acceptable in a preliminary screening study. A 50% error. Which is what happens when you misread tick marks or forget your reconstitution ratio. Makes the data unusable.

Reconstitution Best Practices to Ensure Accurate Dosing

Reconstitution creates the dose-per-tick relationship, so errors here propagate through every subsequent injection. Use only bacteriostatic water (0.9% benzyl alcohol), never sterile water or saline. Bacteriostatic water inhibits bacterial growth and extends peptide stability from 7 days to 28 days under refrigeration. Inject the diluent slowly down the side of the vial. Never directly onto the lyophilized powder. Let the liquid dissolve the peptide passively for 60–90 seconds before gently swirling (never shaking) to complete dissolution.

Measure the diluent volume precisely using the same syringe type you'll use for dosing. Adding 2.0ml when your calculation assumes 2.1ml creates a 5% concentration error. After reconstitution, draw a test volume. Pull exactly 0.1ml (10 ticks) and verify it against the barrel markings under good lighting. This confirms your syringe is calibrated correctly and your reconstitution math matches reality.

Label the vial with three pieces of information: (1) reconstitution date, (2) concentration in mg/ml, (3) dose per tick in micrograms. Example label: '10mg/2ml (5mg/ml). 50mcg per tick. Reconstituted 2026-03-15'. Store refrigerated at 2–8°C in the original vial. Peptides like Thymalin require identical labeling discipline. The compound changes, the protocol doesn't.

The most reliable way to avoid reconstitution errors entirely is to use pre-calculated protocols. Real Peptides provides exact reconstitution guides for every research-grade peptide we supply. Each one maps concentration, tick count, and target dose for standard vial sizes. You can explore high-purity research peptides designed for lab precision, with dosing protocols built into the product documentation.

If you're reconstituting PT-141 for the first time, measure twice and inject once. The peptide is expensive, the research timeline is fixed, and a dosing error three weeks into a protocol means starting over. Get the tick math right before the first injection. Not after the second one feels wrong.

References

Peer-reviewed sources on PT-141 (Bremelanotide) indexed in PubMed, listed for research context. Real Peptides supplies PT-141 (Bremelanotide) for laboratory research use only.

Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. Journal of sex research, 2024. PMID 36809187. doi:10.1080/00224499.2023.2175192
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Expert opinion on pharmacotherapy, 2023. PMID 36242769. doi:10.1080/14656566.2022.2132144
Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 2022. PMID 35076581. doi:10.3390/neurolint14010006
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS spectrums, 2022. PMID 33455598. doi:10.1017/S109285292100002X
Safety Profile of Bremelanotide Across the Clinical Development Program. Journal of women's health (2002), 2022. PMID 35147466. doi:10.1089/jwh.2021.0191
Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. Journal of women's health (2002), 2022. PMID 35230162. doi:10.1089/jwh.2021.0225
Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women. Journal of sex research, 2021. PMID 33678061. doi:10.1080/00224499.2021.1885601
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent. Drug and therapeutics bulletin, 2021. PMID 34642243. doi:10.1136/dtb.2021.000020

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions